Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines

Three Brothers Health submits:

On Monday, a consortium of drug companies lobbied the FDA, saying, “products that include acetaminophen (Tylenol) should stay on the market” despite concerns of widespread liver damage. Drug manufacturers offered to more clearly “warn buyers about the risks of liver damage linked to the Tylenol” instead of the FDA’s more drastic options: a full-out ban.

Too much Tylenol has been causing acute fulminate liver failure for decades. So why is the FDA acting now? FDA officials are specifically worried about “cold and cough” products that combine Tylenol with other medications. Patients can be at risk, by unknowingly, taking too much of these medication. According to Reuters, "FDA officials consider the ingredient safe when taken as directed but worry that the growing number of liver failure cases shows that overdose remains a serious public health problem." Furthermore, the FDA wants to lower the maximum daily dose of acetaminophen. The FDA wants stronger warnings on the following product: Tylenol, Vicks Formula 44, NyQuil, Theraflu, Percocet, Robitussin Cough Cold & Flu, Dristan Cold and other drugs that use acetaminophen.

Read More

Comment on "Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines"

• 3 Financial ETFs Most Influenced By New Bank Rules
• Hendry's Eclectica Builds Asian Bear Portfolio to Hedge Against Hyperinflation
• China Biotech Week in Review: Deals Abound
• Earnings Review: Staples, Salesforce.com, Gamestop
• Top 5 Graphs of the Week: GDP and Inflation Update